Hi-Risk/Recurrent/Advanced PCa Video Chat, May 13, 2025

It’s GreatNonProfits time of year for AnCan participants! Each year we need 10 new endorsements to retain our GreatNonProfits Seal, so if you’re relatively new &/or have not endorsed us previously, now’s the time. Just click https://greatnonprofits.org/org/ancan-foundation and tell the short version of why you love AnCan Foundation…. THANK YOU!
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix, Blue Earth Diagnostic and Foundation Medicine.
If you missed any recent recordings, you’ll find a full list either on our YouTube Playlist or visit our Blog Post https://ancan.org/our-recent-blog-posts-in-case-you-missed-them/   Sign up for our Blog by checking the New Blog box at https://ancan.org/contact-us/
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Join our other free and drop in groups:

Editor’s Pick: Pluvicto shows results after 2 treatments (rd)

Topics Discussed

Surgery vs RT choice for high risk Newbie; PARP failing BRCA1 Gent – what next .. 2nd opinion!; 6-wk testing schedule leads to stable PSA; doing well post recurrence treatment; argon laser beats hyperbaric chamber to treat RT proctitis for our USN diver; Dr. Oh says wait on HT; GU MO in S. Florida; Jevtana holds advnced disease but kidney causes hospitalization; GU MO recommendation at Langone, Madison; unclear recurrence needs Dr. Heath’s eye at Mayo, Rochester.

Chat Log

  • AnCan – rick sent: 4:17 PM

  • Len Sierra sent: 4:37 PM

    Phase 2 study of ADT vs. darolutamide monotherapy: https://pubmed.ncbi.nlm.nih.gov/38272747/

  • Jim Marshall, Alexandria, VA sent: 4:54 PM

    It is called “Testosterone Flair”.

  • Julian – Houston sent: 4:55 PM

  • Jim Cavanaugh sent: 4:58 PM

    Gleason 8 90% of most of 12 cores. on oqgovyx. Prayers to all. Could not figure lock icon in browser

  • AnCan – rick sent: 4:59 PM

    GoTo Helpline 877 582 7011 222-583-97

  • Jim Cavanaugh sent: 5:00 PM

    yes. have been on with Ron Ferraro. Chaplain Jim